Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

Cancer

Volumn 86, Issue 11, 1999, Pages 2364-2369

  Hussain, Maha ^a,c   Gadgeel, Shirish ^a   Kucuk, Omer ^a   Du, Wei ^a   Salwen, Walter ^b   Ensley, John ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

5 fluorouracil; Cisplatin; Paclitaxel; Squamous cell carcinoma of the head and neck

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033452294     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991201)86:11<2364::AID-CNCR26>3.0.CO;2-3     Document Type: Article

References (22)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: the Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-90.
2. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 1998;16:1310-7.
3. Hussain M, Benedetti J, Smith RE, Rodriguez GI, Schuller D, Ensley J, et al. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck. Cancer 1995;76:1233-7.
4. Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 1992;10:1245-51.
5. Kish JA, Weaver A, Jacobs I, Cummings G, Al-Sarraf M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 1984 53;1819-24.
6. Rowland KM, Taylor SG, Spiers AS, DeConti RS, O'Donnell, Showel J, et al. Cisplatin and 5-fluorouracil infusion chemotherapy in advanced recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep 1986;70:461-4.
7. Dasmahapatra KS, Citrin P, Hill GJ, Yee R, Mohit-Tabatabai, Rush BF, et al. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous cell cancer of the head and neck. J Clin Oncol 1985;3:1486-9.
8. Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochester H, et al. A phase II randomised study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992;10:257-63.
9. Forastiere AA, Shank D, Neuberg D, Taylor SG, DeConti RC, Adams G. Final report of a phase II evaluation of paclitaxel with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Cancer 1998;82:2270-4.
10. Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Deniers GW, et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 1996;2:72-9.
11. Brachman DG, Graves D, Vokes H, Beckett M, Haraf D, Montag A, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992;52:4832-6.
12. Parker RJ, Lee KB, Dabholkar M, Bostick-Bruton F, Simmons M, Reed E, et al. Influence of Taxol: cisplatin sequencing on cisplatin-DNA adduct repair in human ovarian cancer cells. Proc Am Assoc Cancer Res 1993;34:21-2.
13. Rowinsky EK. Paclitaxel pharmacology and other tumor types. Semin Oncol 1997;24,6S19:1-12.
14. Kramwe S, Gelber RD, Snow JB, et al. Preoperative v/s postoperative radiation therapy for patients with carcinoma of the head and neck: progress report. Head Neck Surg 1985;3: 255-9.
15. Schantz SP, Harrison LB, Forastiere AA. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: DeVita VT, Hellman S, Rosenberg SA. Cancer principles and practice of oncology. 5th edition. Philadelphia: Lippincott-Raven, 1997:741-801.
16. Rowinsky EK, Gilbert MR, McGuire WP, et al. Sequences of Taxol and cisplatin: a phase I and pharmacologic study. J Clin Oncol 1991;9:1692-703.
17. Dunphy F, Boyd J, Dunleavy T. Paclitaxel and carboplatin in head and neck cancer. Semin Oncol 1997;24(19 Suppl):25-7.
18. Fountzilas G, Athanassiades A, Kalogera-Fountizila A, Samantas E, Bacoyiannis C, Briassoulis E et al. Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer. Semin Oncol 1997; 24(19 Suppl):28-32.
19. Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, et al. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol 1998;16:1325-30.
20. Forastiere AA, Leong T, Rowinsky ME, DeConti R, Karp G, Adams G. A phase III trial of high-dose paclitaxel + cisplatin + G-CSF versus low-dose paclitaxel + cisplatin in patients with advanced squamous cell carcinoma of the head and neck (HNSCC): an Eastern Cooperative Oncology Group trial [abstract]. Proc Am Soc Clin Oncol 1997;16:384a.
21. Benasso M, Numico G, Rosso R, Merlano M, Ricci I, Gentile A. Chemotherapy for relapsed head and neck cancer : paclitaxel, cisplatin, and 5-flurouracil in chemotherapy-naïve patients: a dose-finding study. Semin Oncol 1997;24(19 Suppl):46-50.
22. Hitt R, Brandariz A, Paz-Ares L, Peña M, Millán J, Guzman C, et al. A phase II study of paclitaxel, cisplatin and 5-fluorouracil in locally advanced head and neck cancer [abstract]. Proc Am Soc Clin Oncol 1998;17:382a.